HOLLY DISIBBIO: Open Payments
NPI 1700423019 · BLUEFIELD, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$733 in 38 payments from 7 companies in 2025. Trend: 2023 $41 · 2024 $144 · 2025 $733
Food & beverage: $733
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $346 |
| Teva Pharmaceuticals USA, Inc. | 6 | $99 |
| Vanda Pharmaceuticals Inc. | 4 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $61 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $61 |
| E.R. Squibb & Sons, L.L.C. | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 2 | $38 |
Products named: VRAYLAR, AUSTEDO XR, TRINTELLIX, COBENFY, FANAPT, REXULTI, SPRAVATO, INVEGA SUSTENNA.
Industry payments across VA — which companies pay providers there.
